vs
コヒーレント（COHR）とEncompass Health Corp（EHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
コヒーレントの直近四半期売上が大きい（$1.7B vs $1.5B、Encompass Health Corpの約1.1倍）。Encompass Health Corpの純利益率が高く（9.5% vs 8.7%、差は0.8%）。コヒーレントの前年同期比売上増加率が高い（17.5% vs 9.9%）。Encompass Health Corpの直近四半期フリーキャッシュフローが多い（$116.7M vs $-95.7M）。過去8四半期でコヒーレントの売上複合成長率が高い（18.1% vs 8.3%）
コヒーレントコーポレーションは米国発祥の光学材料・半導体メーカーです。2023年時点の従業員数は26,622人で、2022年にII-VI社がレーザーメーカーのコヒーレント社を買収したことで現在の社名に変更されました。製品は通信、産業、医療など多分野で活用されています。
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
COHR vs EHC — 直接比較
損益計算書 — Q2 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.7B | $1.5B |
| 純利益 | $146.7M | $146.1M |
| 粗利率 | 36.9% | — |
| 営業利益率 | 10.0% | 16.7% |
| 純利益率 | 8.7% | 9.5% |
| 売上前年比 | 17.5% | 9.9% |
| 純利益前年比 | 41.9% | 20.8% |
| EPS（希薄化後） | $0.76 | $1.43 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.7B | $1.5B | ||
| Q3 25 | $1.6B | $1.5B | ||
| Q2 25 | $1.5B | $1.5B | ||
| Q1 25 | $1.5B | $1.5B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | $1.3B | $1.4B | ||
| Q2 24 | $1.3B | $1.3B | ||
| Q1 24 | $1.2B | $1.3B |
| Q4 25 | $146.7M | $146.1M | ||
| Q3 25 | $226.3M | $126.5M | ||
| Q2 25 | $-95.6M | $142.1M | ||
| Q1 25 | $15.7M | $151.5M | ||
| Q4 24 | $103.4M | $120.9M | ||
| Q3 24 | $25.9M | $108.2M | ||
| Q2 24 | $-48.4M | $114.1M | ||
| Q1 24 | $-13.2M | $112.5M |
| Q4 25 | 36.9% | — | ||
| Q3 25 | 36.6% | — | ||
| Q2 25 | 35.7% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 35.5% | — | ||
| Q3 24 | 34.1% | — | ||
| Q2 24 | 32.9% | — | ||
| Q1 24 | 30.3% | — |
| Q4 25 | 10.0% | 16.7% | ||
| Q3 25 | 13.7% | 14.9% | ||
| Q2 25 | -4.1% | 16.2% | ||
| Q1 25 | 0.7% | 16.4% | ||
| Q4 24 | 9.0% | 14.3% | ||
| Q3 24 | 1.4% | 13.6% | ||
| Q2 24 | 4.8% | 14.3% | ||
| Q1 24 | 1.8% | 13.6% |
| Q4 25 | 8.7% | 9.5% | ||
| Q3 25 | 14.3% | 8.6% | ||
| Q2 25 | -6.3% | 9.7% | ||
| Q1 25 | 1.0% | 10.4% | ||
| Q4 24 | 7.2% | 8.6% | ||
| Q3 24 | 1.9% | 8.0% | ||
| Q2 24 | -3.7% | 8.8% | ||
| Q1 24 | -1.1% | 8.5% |
| Q4 25 | $0.76 | $1.43 | ||
| Q3 25 | $1.19 | $1.24 | ||
| Q2 25 | $-0.81 | $1.39 | ||
| Q1 25 | $-0.11 | $1.48 | ||
| Q4 24 | $0.44 | $1.18 | ||
| Q3 24 | $-0.04 | $1.06 | ||
| Q2 24 | $-0.52 | $1.12 | ||
| Q1 24 | $-0.29 | $1.10 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $863.7M | $72.2M |
| 総負債低いほど良い | $3.4B | $2.4B |
| 株主資本純資産 | $8.5B | $2.4B |
| 総資産 | $15.1B | $7.1B |
| 負債/資本比率低いほどレバレッジが低い | 0.39× | 1.00× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $863.7M | $72.2M | ||
| Q3 25 | $852.8M | $48.7M | ||
| Q2 25 | $909.2M | $99.1M | ||
| Q1 25 | $890.3M | $95.8M | ||
| Q4 24 | $917.8M | $85.4M | ||
| Q3 24 | $1.0B | $147.8M | ||
| Q2 24 | $926.0M | $154.4M | ||
| Q1 24 | $898.6M | $134.4M |
| Q4 25 | $3.4B | $2.4B | ||
| Q3 25 | $3.3B | $2.4B | ||
| Q2 25 | $3.7B | $2.3B | ||
| Q1 25 | $3.7B | $2.3B | ||
| Q4 24 | $3.9B | $2.4B | ||
| Q3 24 | $4.0B | $2.3B | ||
| Q2 24 | $4.1B | $2.7B | ||
| Q1 24 | $4.2B | $2.7B |
| Q4 25 | $8.5B | $2.4B | ||
| Q3 25 | $5.8B | $2.4B | ||
| Q2 25 | $5.6B | $2.3B | ||
| Q1 25 | $5.4B | $2.2B | ||
| Q4 24 | $5.2B | $2.1B | ||
| Q3 24 | $5.5B | $2.0B | ||
| Q2 24 | $5.2B | $1.8B | ||
| Q1 24 | $5.3B | $1.7B |
| Q4 25 | $15.1B | $7.1B | ||
| Q3 25 | $14.7B | $6.9B | ||
| Q2 25 | $14.9B | $6.8B | ||
| Q1 25 | $14.4B | $6.6B | ||
| Q4 24 | $14.2B | $6.5B | ||
| Q3 24 | $14.7B | $6.5B | ||
| Q2 24 | $14.5B | $6.4B | ||
| Q1 24 | $14.5B | $6.2B |
| Q4 25 | 0.39× | 1.00× | ||
| Q3 25 | 0.57× | 1.01× | ||
| Q2 25 | 0.65× | 1.02× | ||
| Q1 25 | 0.70× | 1.08× | ||
| Q4 24 | 0.75× | 1.14× | ||
| Q3 24 | 0.73× | 1.20× | ||
| Q2 24 | 0.79× | 1.46× | ||
| Q1 24 | 0.78× | 1.54× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $57.9M | $346.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $-95.7M | $116.7M |
| FCFマージンFCF / 売上 | -5.7% | 7.6% |
| 設備投資強度設備投資 / 売上 | 9.1% | 14.8% |
| キャッシュ転換率営業CF / 純利益 | 0.39× | 2.37× |
| 直近12ヶ月FCF直近4四半期 | $-103.6M | $439.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $57.9M | $346.0M | ||
| Q3 25 | $46.0M | $270.8M | ||
| Q2 25 | $130.3M | $270.2M | ||
| Q1 25 | $163.0M | $288.6M | ||
| Q4 24 | $187.4M | $278.8M | ||
| Q3 24 | $153.0M | $267.8M | ||
| Q2 24 | $162.3M | $217.4M | ||
| Q1 24 | $117.4M | $238.8M |
| Q4 25 | $-95.7M | $116.7M | ||
| Q3 25 | $-58.0M | $83.7M | ||
| Q2 25 | $-1.1M | $113.3M | ||
| Q1 25 | $51.1M | $125.5M | ||
| Q4 24 | $81.7M | $80.1M | ||
| Q3 24 | $61.0M | $120.3M | ||
| Q2 24 | $62.4M | $60.5M | ||
| Q1 24 | $24.2M | $99.4M |
| Q4 25 | -5.7% | 7.6% | ||
| Q3 25 | -3.7% | 5.7% | ||
| Q2 25 | -0.1% | 7.8% | ||
| Q1 25 | 3.4% | 8.6% | ||
| Q4 24 | 5.7% | 5.7% | ||
| Q3 24 | 4.5% | 8.9% | ||
| Q2 24 | 4.7% | 4.6% | ||
| Q1 24 | 2.0% | 7.6% |
| Q4 25 | 9.1% | 14.8% | ||
| Q3 25 | 6.6% | 12.7% | ||
| Q2 25 | 8.6% | 10.8% | ||
| Q1 25 | 7.5% | 11.2% | ||
| Q4 24 | 7.4% | 14.1% | ||
| Q3 24 | 6.8% | 10.9% | ||
| Q2 24 | 7.6% | 12.1% | ||
| Q1 24 | 7.7% | 10.6% |
| Q4 25 | 0.39× | 2.37× | ||
| Q3 25 | 0.20× | 2.14× | ||
| Q2 25 | — | 1.90× | ||
| Q1 25 | 10.37× | 1.90× | ||
| Q4 24 | 1.81× | 2.31× | ||
| Q3 24 | 5.91× | 2.48× | ||
| Q2 24 | — | 1.91× | ||
| Q1 24 | — | 2.12× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
COHR
| Datacenter And Communications Segment | $1.2B | 72% |
| Industrial Segment | $477.7M | 28% |
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
